114 related articles for article (PubMed ID: 241654)
1. Neuroleptic antagonism of dyskinetic phenomena.
Costall B; Naylor RJ
Eur J Pharmacol; 1975; 33(2):301-12. PubMed ID: 241654
[TBL] [Abstract][Full Text] [Related]
2. Dissociation of stereotyped biting responses and oro-bucco-lingual dyskinesias.
Costall B; Naylor RJ
Eur J Pharmacol; 1976 Apr; 36(2):423-9. PubMed ID: 945168
[TBL] [Abstract][Full Text] [Related]
3. Dyskinetic phenomena caused by the intrastriatal injection of phenylethylamine, phenylpiperazine, tetrahydroisoquinoline and tetrahydronaphthalene derivatives in the guinea pig.
Costall B; Naylor RJ; Pinder RM
Eur J Pharmacol; 1975 Mar; 31(1):94-109. PubMed ID: 1126382
[TBL] [Abstract][Full Text] [Related]
4. A comparison of the abilities of typical neuroleptic agents and of thioridazine, clozapine, sulpiride and metoclopramide to antagonise the hyperactivity induced by dopamine applied intracerebrally to areas of the extrapyramidal and mesolimbic systems.
Costall B; Naylor RJ
Eur J Pharmacol; 1976 Nov; 40(1):9-19. PubMed ID: 791660
[TBL] [Abstract][Full Text] [Related]
5. The effect of dopamine and noradrenaline antagonists on amphetamine induced locomotor activity in mice and rats.
Rolinski Z; Scheel-Krüger J
Acta Pharmacol Toxicol (Copenh); 1973; 33(5):385-99. PubMed ID: 4149038
[No Abstract] [Full Text] [Related]
6. [Relationship between gnawing compulsion and central dopaminergic mechanism in guinea pigs (author's transl)].
Uemura H
Nihon Yakurigaku Zasshi; 1979 Jan; 75(1):61-72. PubMed ID: 571393
[TBL] [Abstract][Full Text] [Related]
7. Antagonism of the hyperactivity induced by dopamine applied intracerebrally to the nucleus accumbens septi by typical neuroleptics and by clozapine, sulpiride and thioridazine.
Costall B; Naylor RJ
Eur J Pharmacol; 1976 Jan; 35(1):161-8. PubMed ID: 1253817
[TBL] [Abstract][Full Text] [Related]
8. Implications of amphetamine-induced stereotyped behavior as a model for tardive dyskinesias.
Rubovits R; Klawans HL
Arch Gen Psychiatry; 1972 Oct; 27(4):502-7. PubMed ID: 5072718
[No Abstract] [Full Text] [Related]
9. The behavioral pharmacology of butaclamol hydrochloride (AY-23,028), a new potent neuroleptic drug.
Voith K; Herr F
Psychopharmacologia; 1975 Apr; 42(1):11-20. PubMed ID: 1171496
[TBL] [Abstract][Full Text] [Related]
10. The activity of some neuroleptic drugs and amphetamine in normal and isolated rats.
Kostowski W; Czlonkowski A
Pharmacology; 1973; 10(2):82-7. PubMed ID: 4797045
[No Abstract] [Full Text] [Related]
11. Gabaminergic and serotonergic modulation of the antidyskinetic effects of tiapride and oxiperomide in the model using 2-(N,N-dipropyl)animo-5,6-dihydroxytetralin.
Costall B; Naylor RJ; Owen RT
Eur J Pharmacol; 1978 Jun; 49(4):407-13. PubMed ID: 352713
[TBL] [Abstract][Full Text] [Related]
12. Modification of dyskinesias following the intrastriatal injection of prostaglandins in the rodent.
Costall B; Holmes SW; Kelly ME; Naylor RJ
Br J Pharmacol; 1985 Aug; 85(4):943-9. PubMed ID: 3862460
[TBL] [Abstract][Full Text] [Related]
13. Pimozide, a chemically novel, highly potent and orally long-acting neuroleptic drug. I. The comparative pharmacology of pimozide, haloperidol, and chlorpromazine.
Janssen PA; Niemegeers CJ; Schellekens KH; Dresse A; Lenaerts FM; Pinchard A; Schaper WK; van Nueten JM; Verbruggen FJ
Arzneimittelforschung; 1968 Mar; 18(3):261-79. PubMed ID: 4386815
[No Abstract] [Full Text] [Related]
14. Pharmacology of neuroleptics upon repeated administration.
Moller Nielsen I; Fjalland B; Pedersen V; Nymark M
Psychopharmacologia; 1974 Jan; 34(2):95-104. PubMed ID: 4856370
[No Abstract] [Full Text] [Related]
15. The effect of alpha-adrenolytics on central action of agonists and antagonists of dopaminergic system.
Zebrowska-Lupina I
Pol J Pharmacol Pharm; 1977; 29(4):393-404. PubMed ID: 20609
[TBL] [Abstract][Full Text] [Related]
16. Effects of chronic administration of neuroleptics: dyskinesias in monkeys.
Paulson G
Pharmacol Ther B; 1976; 2(1):167-71. PubMed ID: 4829
[No Abstract] [Full Text] [Related]
17. Dopamine antagonistic effects of a series of analogues of oxiperomide and spiroxatrine measured behaviourally in the rodent.
Costall B; Naylor RJ
J Pharm Pharmacol; 1978 Nov; 30(11):693-8. PubMed ID: 31432
[TBL] [Abstract][Full Text] [Related]
18. The nucleus amygdaloideus centralis and neuroleptic activity in the rat.
Costall B; Naylor RJ
Eur J Pharmacol; 1974 Feb; 25(2):138-46. PubMed ID: 4154850
[No Abstract] [Full Text] [Related]
19. Behavioural correlates to the dopamine D-1 and D-2 antagonists.
Christensen AV; Arnt J; Hyttel J; Svendsen O
Pol J Pharmacol Pharm; 1984; 36(2-3):249-64. PubMed ID: 6147830
[TBL] [Abstract][Full Text] [Related]
20. Differential activation by some 2-aminotetralin derivatives of the receptor mechanisms in the nucleus accumbens of rats which mediate hyperactivity and stereotyped biting.
Costall B; Naylor RJ; Cannon JG; Lee T
Eur J Pharmacol; 1977 Feb; 41(3):307-19. PubMed ID: 556988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
